ReP USP - Resultado da busca

Trabalho de evento
Valorization of waste graphite deriving from "end of life lithium-ion battery recycling" for a second use in wastewater treatment (2023)
Premathilake, Dilshan Sandaruwan ; Botelho Junior, Amilton Barbosa ; Colombi, Francesca; Tenório, Jorge Alberto Soares ; Vaccari, Mentore ; Espinosa, Denise Crocce Romano
Source: CEST 2023. Conference titles: International Conference on Environmental Science and Technology. Unidade: EP
Subjects: TRATAMENTO DE ÁGUAS RESIDUÁRIAS, ADSORÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PREMATHILAKE, Dilshan Sandaruwan et al. Valorization of waste graphite deriving from "end of life lithium-ion battery recycling" for a second use in wastewater treatment. 2023, Anais.. Athens, Greece: Global Network of Environmental Science and Technology, 2023. Disponível em: 10.30955/gnc2023.00266. Acesso em: 08 out. 2025.
APA
Premathilake, D. S., Botelho Junior, A. B., Colombi, F., Tenório, J. A. S., Vaccari, M., & Espinosa, D. C. R. (2023). Valorization of waste graphite deriving from "end of life lithium-ion battery recycling" for a second use in wastewater treatment. In CEST 2023. Athens, Greece: Global Network of Environmental Science and Technology. doi:DOI: 10.30955/gnc2023.00266
NLM
Premathilake DS, Botelho Junior AB, Colombi F, Tenório JAS, Vaccari M, Espinosa DCR. Valorization of waste graphite deriving from "end of life lithium-ion battery recycling" for a second use in wastewater treatment [Internet]. CEST 2023. 2023 ;[citado 2025 out. 08 ] Available from: 10.30955/gnc2023.00266
Vancouver
Premathilake DS, Botelho Junior AB, Colombi F, Tenório JAS, Vaccari M, Espinosa DCR. Valorization of waste graphite deriving from "end of life lithium-ion battery recycling" for a second use in wastewater treatment [Internet]. CEST 2023. 2023 ;[citado 2025 out. 08 ] Available from: 10.30955/gnc2023.00266
Artigo de periodico
Targeting glioma cells by antineoplastic activity of reversine (2021)
Hirakata, Camila Yumi Soares ; Lima, Keli ; Almeida, Bruna Oliveira De ; Miranda, Lívia Bassani Lins De ; Florêncio, Katharine Gurgel Dias ; Furtado, Luciana Costa ; Costa-Lotufo, Letícia Veras ; Machado Neto, João Agostinho
Source: Oncology Letters. Unidade: ICB
Subjects: FARMACOLOGIA, APOPTOSE, PROTEÍNAS QUINASES, GLIOMA, NEOPLASIAS CEREBRAIS, CÉLULAS CULTIVADAS DE TUMOR, ANTINEOPLÁSICOS, REAÇÃO EM CADEIA POR POLIMERASE, WESTERN BLOTTING
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRAKATA, Camila Yumi Soares et al. Targeting glioma cells by antineoplastic activity of reversine. Oncology Letters, v. 22, n. 2, p. 1-9, 2021Tradução . . Disponível em: https://doi.org/10.3892/ol.2021.12871. Acesso em: 08 out. 2025.
APA
Hirakata, C. Y. S., Lima, K., Almeida, B. O. D., Miranda, L. B. L. D., Florêncio, K. G. D., Furtado, L. C., et al. (2021). Targeting glioma cells by antineoplastic activity of reversine. Oncology Letters, 22( 2), 1-9. doi:10.3892/ol.2021.12871
NLM
Hirakata CYS, Lima K, Almeida BOD, Miranda LBLD, Florêncio KGD, Furtado LC, Costa-Lotufo LV, Machado Neto JA. Targeting glioma cells by antineoplastic activity of reversine [Internet]. Oncology Letters. 2021 ; 22( 2): 1-9.[citado 2025 out. 08 ] Available from: https://doi.org/10.3892/ol.2021.12871
Vancouver
Hirakata CYS, Lima K, Almeida BOD, Miranda LBLD, Florêncio KGD, Furtado LC, Costa-Lotufo LV, Machado Neto JA. Targeting glioma cells by antineoplastic activity of reversine [Internet]. Oncology Letters. 2021 ; 22( 2): 1-9.[citado 2025 out. 08 ] Available from: https://doi.org/10.3892/ol.2021.12871
Artigo de periodico
PARP‑1 inhibition sensitizes temozolomide‑treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency (2020)
Montaldi, Ana P.; Lima, Sarah Caroline Gomes de ; Godoy, Paulo Roberto D'Auria Vieira; Xavier, Danilo Jordão; Sakamoto-Hojo, Elza Tiemi
Source: Oncology Reports. Unidades: FFCLRP, FMRP
Subjects: ANTINEOPLÁSICOS, FARMACOLOGIA, APOPTOSE, NEOPLASIAS CEREBRAIS, PATOLOGIA, GLIOMA, METABOLISMO, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTALDI, Ana P. et al. PARP‑1 inhibition sensitizes temozolomide‑treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency. Oncology Reports, v. 44, n. 5, p. 2275-2287, 2020Tradução . . Disponível em: https://doi.org/10.3892/or.2020.7756. Acesso em: 08 out. 2025.
APA
Montaldi, A. P., Lima, S. C. G. de, Godoy, P. R. D. 'A. V., Xavier, D. J., & Sakamoto-Hojo, E. T. (2020). PARP‑1 inhibition sensitizes temozolomide‑treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency. Oncology Reports, 44( 5), 2275-2287. doi:10.3892/or.2020.7756
NLM
Montaldi AP, Lima SCG de, Godoy PRD'AV, Xavier DJ, Sakamoto-Hojo ET. PARP‑1 inhibition sensitizes temozolomide‑treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency [Internet]. Oncology Reports. 2020 ; 44( 5): 2275-2287.[citado 2025 out. 08 ] Available from: https://doi.org/10.3892/or.2020.7756
Vancouver
Montaldi AP, Lima SCG de, Godoy PRD'AV, Xavier DJ, Sakamoto-Hojo ET. PARP‑1 inhibition sensitizes temozolomide‑treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency [Internet]. Oncology Reports. 2020 ; 44( 5): 2275-2287.[citado 2025 out. 08 ] Available from: https://doi.org/10.3892/or.2020.7756

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em